long-chain polyunsaturated derivatives of the essential fatty acids (LC-PUFA), namely arachidonic acid (AA) and docosahexaenoic acid (DHA). Vegetarians with marginal dietary intakes of LC-PUFA showed similar LC-PUFA content in breast milk compared to mothers consuming omnivorous diets [8] . Mobilization from body fat or another large endogenous pool of LC-PUFA, which may serve as a substrate source for milk production, might guarantee a more constant supply of LC-PUFA which appear to be of importance for infant development [9] .
Quantitative determinations of dietary intake and milk output of a fatty acid cannot distinguish different sources from which milk fatty acids are derived. Rather, the application of stable isotope labeled analogues offers the possibility to elucidate the processes involved in the transfer of a fatty acid into milk either unchanged or as one of its conversion products. Since the use of stable isotope tracers in clinical investigations is safe and without adverse effects even in newborn infants [10] , they can be used to study the physiology of substrate flux in lactation.
Hachey et al. [11] applied deuterated fatty acids to breast-feeding women and estimated from their results that only 29% of palmitic, oleic and linoleic acids incorporated into human milk fat within 72 h were derived from isotopically labeled dietary fatty acids during late lactation [11] . These findings suggest four major routes for the metabolism of dietary LA in lactating women: oxidation, direct transfer into milk, incorporation into body stores and conversion into metabolites other than CO 2 . In an attempt to quantify these pathways, we studied the metabolic disposal of dietary LA in 6 healthy lactating women consuming omnivorous diets [12] . All women were breast-feeding one term infant and were studied repeatedly in the 2nd, 6th and 12th week of lactation. During each observation period, they continued their usual dietary habits. At the start of each study period, the women received 1 mg/kg body weight of uniformly 13 Clabeled LA as one bolus dose.
Milk samples were obtained during 5 days, starting in the morning of the first study day before tracer application. A total of 15 samples was collected at time points 0, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78, 84, 96, 102 and 108 h after the tracer intake. Daily milk production was determined by weighing the infant before and after feeding. Breath samples were collected by standard procedures before breakfast on the first study day, in hourly intervals until 12 h after start, and during the following 4 days at the same time points when milk was sampled. Since it was technically not feasible to perform measurements of total CO 2 production, a value of 300 mmol CO 2 /m² of body surface per hour was assumed. Quantitative analysis of milk samples was performed as described by GenzelBoroviczény et al. [13] . 13 C content of fatty acid methyl esters and exhaled CO 2 was analyzed by gas chromatography combustion isotope ratio mass spectrometry with the analytical setup described previously [12] .
We considered four exit routes for the tracer, namely milk LA, dihomo-γ-linolenic acid and AA as well as breath CO 2 . In table 1, the corresponding recoveries for the first 24 h and for the whole observation period of 108 h are presented. It is obvious that a sizeable portion of the tracer (50-80%) was not recovered with the applied approach. Several reasons need to be considered to explain this unrecovered tracer portion, e.g. incorporation of 13 C into other components such as short-and medium-chain fatty acids which were not measured. Furthermore considerable portions of lipid tracers catabolized in energy metabolism are not recovered in breath [14] . Even considering these possible metabolic routes for part of the tracer, it appears probable that a considerable portion of the tracer is also incorporated into large-body pools with slow turnover, resulting in a delayed appearance with low levels of enrichment in the sampled compounds.
The recovery determined after 5 days cannot be ascribed to direct transfer into milk or breath from the diet, as it has to be expected that the label recovered after several days was stored in pools with slow turnover and thus was not transferred directly from the diet. To choose any shorter time interval seems to be somewhat arbitrary and not well justifiable on the grounds of known physiology. For this reason, we have constructed a compartmental model, with 3 body pools for LA, including 1 pool with a slow turnover and no direct flux from this pool into milk or breath [12] . With this model, we calculated a direct transfer of 8.9 ± 1.1% (mean ± SE) of the tracer into milk LA, if direct transfer is defined as the probability of dietary LA to be excreted into milk without entering the slow Table 1 . Fractional recovery (mean ± SE) of orally applied 13 C-LA in 6 lactating women 24 and 108 h after tracer intake in exhaled CO 2 and milk LA, dihomo-γ-linolenic acid (DGLA) and AA, studied in the 2nd, 6th and 12th week of lactation turnover pool. This result is well within the range defined by the cumulative recoveries after 12 and 108 h.
With respect to the LC-PUFA derivatives, we conclude that the current dietary intake of LA is not the major precursor for milk dihomo-γ-linolenic acid and AA, since less than 0.3% of the LA tracer were recovered in its LC-PUFA metabolites. However, this does not exclude dietary LA as a source for milk LC-PUFA, because the LA incorporated into body stores may be a precursor for LC-PUFA synthesis in maternal tissues. In this case, the body pools of dihomo-γ-linolenic acid and AA might well be large enough to introduce a sufficient dilution of the 13 C-enriched LC-PUFA synthesized from the LA tracer to make it undetectable with the methodology used in our study. In fact, the observed kinetics of AA enrichment in milk, which did not reach a maximum 13 C enrichment during the observation period of 5 days, appear to reflect a continued transfer of AA into milk synthesized from 13 C-labeled LA in maternal tissues. There was no indication of a relationship between the transfer of labeled LA into milk and dietary LA intake (5-16 g/day). This is in agreement with the reported immediate effect of dietary fatty acid intake on the fatty acid composition of milk [15] and opens the possibility to influence milk fat composition by maternal dietary supplementation.
Therefore, we tested the effect of dietary supplementation with a DHA-rich oil (200 mg DHA/day) on the metabolic partitioning in lactating women. In this study two groups of 5 lactating women each consumed either the DHA-rich oil or a placebo oil without LC-PUFA for 2 weeks from the 4th week of lactation onwards. The supplementation resulted in a markedly different DHA content of the milk at the end of the supplementation period (0.37 vs. 0.21% w/w; p < 0.001). On the 14th day of the intervention period, both groups ingested 2 mg/kg body weight of the same DHA-rich oil, but uniformly labeled with 13 C. The recovery of 13 CO 2 in breath during 48 h after tracer intake was identical in both groups (15.4 vs. 15.6%; DHA-rich oil vs. placebo) [16] . Also, the cumulative recovery of DHA in milk was not significantly different between groups (9.1 vs. 8.0%) [17] . Thus, an increased intake of DHA in lactating women does not down-regulate DHA transfer into milk and is an effective way to enhance milk DHA levels.
Although maternal diet clearly affects the composition of human milk, these studies using stable isotope methodology show that only a minor proportion of dietary fatty acids is directly transferred into milk, whereas maternal body pools are the major contributors to milk fatty acids, including PUFA and LC-PUFA. Hence, short-term variations of dietary fat composition are buffered to some extent by intermediate incorporation into storage pools, and the PUFA and particularly LC-PUFA content in human milk as well as the supply to the breastfed infant remains relatively constant [18] . It is tempting to speculate that this metabolic buffer benefits the breast-fed infant by reducing the variability in dietary supply of these essential substrates with great biological relevance for early human development. Part of the maternal dietary fatty acid intake, however, is directly transferred into milk, probably without significant influence of dietary intake in the tested ranges. This enables the possibility to influence milk fat composition by supplementing the diet of lactating mothers.
